company background image
300601 logo

Shenzhen Kangtai Biological Products XSEC:300601 Stock Report

Last Price

CN¥14.62

Market Cap

CN¥16.3b

7D

-9.1%

1Y

-41.8%

Updated

10 Jan, 2025

Data

Company Financials +

Shenzhen Kangtai Biological Products Co., Ltd.

XSEC:300601 Stock Report

Market Cap: CN¥16.3b

300601 Stock Overview

Shenzhen Kangtai Biological Products Co., Ltd. More details

300601 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth5/6
Past Performance3/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 74% below our estimate of its fair value

Earnings are forecast to grow 38.34% per year

Earnings grew by 42.7% over the past year

Trading at good value compared to peers and industry

Risk Analysis

Large one-off items impacting financial results

Dividend of 2.74% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

Shenzhen Kangtai Biological Products Co., Ltd. Competitors

China Resources Boya Bio-pharmaceutical GroupLtd

SZSE:300294

CN¥14.4b

Walvax Biotechnology

SZSE:300142

CN¥17.5b

Gan & Lee Pharmaceuticals

SHSE:603087

CN¥24.5b

Yantai Dongcheng Pharmaceutical GroupLtd

SZSE:002675

CN¥10.0b

Price History & Performance

Summary of share price highs, lows and changes for Shenzhen Kangtai Biological Products
Historical stock prices
Current Share PriceCN¥14.62
52 Week HighCN¥25.59
52 Week LowCN¥12.93
Beta0.85
1 Month Change-24.05%
3 Month Change-18.60%
1 Year Change-41.82%
3 Year Change-74.95%
5 Year Change-75.58%
Change since IPO-65.09%

Recent News & Updates

Recent updates

Shareholder Returns

300601CN BiotechsCN Market
7D-9.1%-1.5%-1.5%
1Y-41.8%-22.7%5.6%

Return vs Industry: 300601 underperformed the CN Biotechs industry which returned -22.7% over the past year.

Return vs Market: 300601 underperformed the CN Market which returned 5.6% over the past year.

Price Volatility

Is 300601's price volatile compared to industry and market?
300601 volatility
300601 Average Weekly Movement6.2%
Biotechs Industry Average Movement6.2%
Market Average Movement7.2%
10% most volatile stocks in CN Market11.2%
10% least volatile stocks in CN Market4.4%

Stable Share Price: 300601 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300601's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19921,902Xiang Miaowww.biokangtai.com

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines.

Shenzhen Kangtai Biological Products Co., Ltd. Fundamentals Summary

How do Shenzhen Kangtai Biological Products's earnings and revenue compare to its market cap?
300601 fundamental statistics
Market capCN¥16.33b
Earnings (TTM)CN¥515.35m
Revenue (TTM)CN¥3.03b

31.7x

P/E Ratio

5.4x

P/S Ratio

Is 300601 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300601 income statement (TTM)
RevenueCN¥3.03b
Cost of RevenueCN¥645.50m
Gross ProfitCN¥2.39b
Other ExpensesCN¥1.87b
EarningsCN¥515.35m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 21, 2025

Earnings per share (EPS)0.46
Gross Margin78.70%
Net Profit Margin17.00%
Debt/Equity Ratio21.8%

How did 300601 perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 03:32
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Kangtai Biological Products Co., Ltd. is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Diandian LiChina Merchants Securities Co. Ltd.
Bing ZhaoChina Renaissance Securities